These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23636801)

  • 21. Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.
    Lim JC; Koh VC; Tan JS; Tan WJ; Thike AA; Tan PH
    Breast Cancer Res Treat; 2015 Feb; 150(1):19-29. PubMed ID: 25677742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
    Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
    Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
    Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
    Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
    Bernhardt S; Bayerlová M; Vetter M; Wachter A; Mitra D; Hanf V; Lantzsch T; Uleer C; Peschel S; John J; Buchmann J; Weigert E; Bürrig KF; Thomssen C; Korf U; Beissbarth T; Wiemann S; Kantelhardt EJ
    Breast Cancer Res; 2017 Oct; 19(1):112. PubMed ID: 29020998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcome.
    Tan WJ; Thike AA; Bay BH; Tan PH
    Histopathology; 2014 May; 64(6):807-17. PubMed ID: 24438019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMGA2-mediated glutamine metabolism is required for Cd-induced cell growth and cell migration.
    Yang Y; Gao C; Li Q; Liu Y; Cao J
    Toxicology; 2024 Sep; 507():153899. PubMed ID: 39032683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target.
    Bolzoni M; Chiu M; Accardi F; Vescovini R; Airoldi I; Storti P; Todoerti K; Agnelli L; Missale G; Andreoli R; Bianchi MG; Allegri M; Barilli A; Nicolini F; Cavalli A; Costa F; Marchica V; Toscani D; Mancini C; Martella E; Dall'Asta V; Donofrio G; Aversa F; Bussolati O; Giuliani N
    Blood; 2016 Aug; 128(5):667-79. PubMed ID: 27268090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor.
    Lei T; Yin L; Zhang H; Wei B; Chen H; Pu T; Yang L; Ye F; Zhang Z; Bu H
    Int J Clin Oncol; 2020 Dec; 25(12):2025-2034. PubMed ID: 32803488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma.
    Sun HW; Yu XJ; Wu WC; Chen J; Shi M; Zheng L; Xu J
    PLoS One; 2016; 11(12):e0168907. PubMed ID: 28036362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD117 expression in breast phyllodes tumors correlates with adverse pathologic parameters and reduced survival.
    Tan WJ; Thike AA; Tan SY; Tse GM; Tan MH; Bay BH; Tan PH
    Mod Pathol; 2015 Mar; 28(3):352-8. PubMed ID: 25216225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.
    Ho SK; Thike AA; Cheok PY; Tse GM; Tan PH
    Histopathology; 2013 Sep; 63(3):393-406. PubMed ID: 23772632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of redox proteins in phyllodes tumor.
    Kim S; Kim DH; Jung WH; Koo JS
    Breast Cancer Res Treat; 2013 Oct; 141(3):365-74. PubMed ID: 24068538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast.
    Tsang JYS; Hui YK; Lee MA; Lacambra M; Ni YB; Cheung SY; Wu C; Kwong A; Tse GMK
    Sci Rep; 2018 Mar; 8(1):3881. PubMed ID: 29497099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of succinate dehydrogenase in breast phyllodes tumor.
    Choi J; Kim DH; Jung W; Koo JS
    Histol Histopathol; 2014 Oct; 29(10):1343-54. PubMed ID: 24807638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.
    Tan PH; Jayabaskar T; Yip G; Tan Y; Hilmy M; Selvarajan S; Bay BH
    Mod Pathol; 2005 Dec; 18(12):1527-34. PubMed ID: 16258510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.
    Nie Y; Huang H; Guo M; Chen J; Wu W; Li W; Xu X; Lin X; Fu W; Yao Y; Zheng F; Luo ML; Saw PE; Yao H; Song E; Hu H
    Clin Cancer Res; 2019 Jul; 25(13):3873-3886. PubMed ID: 30890553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features.
    Chougule A; Bal A; Das A; Kohli PS; Singh G
    Virchows Arch; 2016 Dec; 469(6):651-658. PubMed ID: 27696244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
    Kim GE; Kim NI; Park MH; Lee JS
    Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors.
    Kim GE; Kim JH; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):298-303. PubMed ID: 22505012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of glutamine metabolism by the tumor suppressor Rb.
    Reynolds MR; Lane AN; Robertson B; Kemp S; Liu Y; Hill BG; Dean DC; Clem BF
    Oncogene; 2014 Jan; 33(5):556-66. PubMed ID: 23353822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.